Remove 2019 Remove Financial Market Remove Investments
article thumbnail

MiB: Jon McAuliffe, the Voleon Group

The Big Picture

This week, we speak with Jon McAuliffe , who is co-founder and chief investment officer at the Voleon Group , heading the firm’s investment strategy, research, and development. Voleon, which manages $10 billion in client assets, has achieved great success applying these technologies to investing.

article thumbnail

Olectra Greentech Vs JBM Auto – Which is the Better Green Investment?

Trade Brains

The table below highlights the revenue and net profit growth of Olectra Greentech Vs JBM Auto over the past five financial years. Particulars / Fiscal Year 2019 2020 2021 2022 2023 Olectra Greentech - Operating Profit Margin - 8.918 2.513 7.172 14.265 10.8 JBM Auto - Net Profit Margin 4.36 and 11.86% in FY23 respectively. times and 2.35

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reading the volatility tea leaves

Nationwide Financial

In times of peaking pessimism and extreme bearishness, investors often try to parse how the financial markets are reflecting an array of risks. After all, understanding risk is a crucial part of the investment process. However, how might the market reflect its trepidations when trying to digest those risks?

article thumbnail

Titagarh Railsystems vs Jupiter Wagons – Future Plans & More

Trade Brains

Industry Analysis The Indian rail freight industry is experiencing growth and improvements, with ambitious plans and increased investment by the government and schemes such as Gati Shakti, which aim at enhancing capacity, efficiency, and sustainability. Particulars/ Financial Year Revenue (Cr.) 2019-20 ₹ 1,766.32 ₹ 125.74

Planning 105
article thumbnail

Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More

Trade Brains

2019-20 ₹ 17,131.99 ₹ 32,837.50 ₹ 1,499.52 ₹ 4,186.79 Particulars/ Financial Year Debt to Equity Interest Coverage Cipla Sun Pharma Cipla Sun Pharma 2022-23 0.02 Market Cap (Cr.) ₹ 97,810 ₹ 2,94,434 RoE 12.60% 15.10% EPS (TTM) ₹ 42.77 ₹ 35.63 Cipla Sun Pharma Cipla Sun Pharma 2022-23 ₹ 22,753.12 ₹ 43,885.68 ₹ 2,832.89 ₹ 8,560.84

article thumbnail

Fundamental Analysis Of Cholamandalam Investment & Finance Company – Future Plans

Trade Brains

Fundamental Analysis Of Cholamandalam Investment & Finance Company: The Murugappa Group is one of India’s leading business conglomerates. Today we will look at an important Financial Institution from the prestigious house of Murugappa Group. 7229 Cr, which increased by 24% from Rs. 5840 Cr in FY22.

article thumbnail

Fundamental Analysis of Tata Investment Corporation – Financials & More

Trade Brains

Fundamental Analysis of Tata Investment Corporation: Did you know you can buy almost all Tata Group stocks for Rs 2,500? Tata Investment Corporation is a listed investment company of the Tata Group which has investments in various Tata Group and non-Tata Group listed and unlisted companies. Don’t you believe us?